Collaboration between the healthcare system and the pharmaceutical industry, key for Spain to consolidate its leadership in clinical trials

Representatives of the Spanish Medicines Agency, patient associations, hospitals and the pharmaceutical industry debate in a webinar on how to promote clinical research in Spain Measures forced by the pandemic such as sending medication to the home or monitoring trials remotely, possible advances for the future Promote clinical research in primary care and in the […]

The clinical trial, a value bet for the healthcare system, professionals, patients and industry.

On May 20, Clinical Trial Day is celebrated worldwide About 80% of the studies that are launched in Spain are driven by the pharmaceutical industry Spain has become an international benchmark, as its leading role in clinical research against coronavirus shows, and it has the opportunity to consolidate that leadership Source: www.farmaindustria.es Clinical research is […]

Novo Nordisk Spain increases patients in clinical trials by 50% in three years

Source: www.immedicohospitalario.es Since 2018, Novo Nordisk Spain has increased the number of patients in clinical trials by 50%, as detailed by Fernando Fuentes, head of Clinical Operations at Novo Nordisk in Spain. In addition, in the last four years, the Danish multinational has invested 19.1 million euros in R&D in our country, an economic amount […]

Almost a thousand clinical trials, more than 230 drugs and vaccines to combat Covid-19

Industrial property is “the main reason why there is such a solid base of innovation from which to work to find solutions,” says the director of the International Federation of the Pharmaceutical Industry.   Source: www.immedicohospitalario.es The health crisis caused by SARS-CoV-2 has created an unprecedented worldwide research effort to find a therapeutic solution as […]

World Asthma Day: fifty hundred medicines in development for one of the most prevalent pathologies

This chronic disease has an incidence of between 3 and 7% of the population in Spain, according to experts Treatments provide clear results in patients’ health and savings for the health system and society as a whole Experts on childhood asthma remember, in the face of the pandemic, not to suspend the usual pharmacological treatments […]

Drug research as an opportunity for Spain

In just a few months, Spain has launched 64 clinical trials with potential anti-coronavirus drugs, ranking first in Europe and fourth in the world. The brutal health crisis caused by Covid-19 that devastates a large part of the world has turned the eyes of authorities, health professionals and the general population towards the pharmaceutical industry […]

Objective: to maintain clinical trials without putting patients’ health at risk

Farmaindustria participates in a Eupati webinar aimed at patients from all over Spain Explain how laboratories are working, in collaboration with researchers and hospitals, so that the health crisis affects as little as possible clinical research Source: www.farmaindustria.es Farmaindustria companies have focused since the beginning of the health crisis in trying to make it affect […]

New clinical trial designs and more resources for Spain to achieve excellence

Via: www.elglobal.es Clinical and industry experts carry out a decalogue with measures to strengthen the Spanish research system In recent years, Spain has positioned itself among the countries in the world with the best conditions to host the development of clinical trials for new drugs. In fact, one out of every three tests carried out […]

Spain, a world leader in conducting clinical trials of new drugs

Via: www.immedicohospitalario.es Farmaindustria has collected in a document the measures that 120 experts from hospital centers and pharmaceutical companies propose to boost Spanish leadership and attract more investment.   Spain has advanced in recent years to position itself among the countries in the world with the best conditions to host the development of clinical trials […]

Exceptional measures for tests for problems derived from the emergency by COVID-19

Source: www.actasanitaria.com The Spanish Agency of Medicines and Health Products (AEMPS), as the competent national authority in the authorization of clinical trials, has proposed a series of recommendations of exceptional application during the period of the COVID-19 crisis in Spain, which are intended to preserve the trial activities as far as possible, guaranteeing the healthcare […]